Baldwin Brothers Inc. MA Maintains Position in CME Group Inc (CME)

Baldwin Brothers Inc. MA held its stake in CME Group Inc (NASDAQ:CME) during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 913 shares of the financial services provider’s stock at the end of the first quarter. Baldwin Brothers Inc. MA’s holdings in CME Group were worth $108,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of the stock. State Street Corp increased its stake in CME Group by 5.7% in the fourth quarter. State Street Corp now owns 17,986,325 shares of the financial services provider’s stock valued at $2,084,930,000 after buying an additional 977,421 shares in the last quarter. FMR LLC increased its stake in CME Group by 5.4% in the fourth quarter. FMR LLC now owns 7,226,868 shares of the financial services provider’s stock valued at $833,618,000 after buying an additional 371,705 shares in the last quarter. JPMorgan Chase & Co. increased its stake in CME Group by 1.3% in the third quarter. JPMorgan Chase & Co. now owns 7,064,945 shares of the financial services provider’s stock valued at $738,427,000 after buying an additional 88,456 shares in the last quarter. Edgewood Management LLC increased its stake in CME Group by 1.4% in the fourth quarter. Edgewood Management LLC now owns 5,716,596 shares of the financial services provider’s stock valued at $659,409,000 after buying an additional 81,244 shares in the last quarter. Finally, Thornburg Investment Management Inc. increased its stake in CME Group by 2.6% in the fourth quarter. Thornburg Investment Management Inc. now owns 4,718,894 shares of the financial services provider’s stock valued at $544,324,000 after buying an additional 117,800 shares in the last quarter. 80.06% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

CME Group Inc (NASDAQ:CME) opened at 119.11 on Friday. CME Group Inc has a 52-week low of $90.69 and a 52-week high of $127.60. The firm has a market capitalization of $40.46 billion, a P/E ratio of 26.29 and a beta of 0.88. The company’s 50-day moving average is $120.33 and its 200-day moving average is $115.89.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Thursday, February 2nd. The financial services provider reported $1.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.03. CME Group had a net margin of 42.67% and a return on equity of 7.28%. The firm earned $913 million during the quarter, compared to analysts’ expectations of $881.46 million. During the same quarter last year, the business earned $0.92 earnings per share. The business’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, analysts predict that CME Group Inc will post $4.84 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 27th. Investors of record on Friday, March 10th were paid a $0.66 dividend. This is a boost from CME Group’s previous quarterly dividend of $0.60. The ex-dividend date was Wednesday, March 8th. This represents a $2.64 annualized dividend and a dividend yield of 2.22%. CME Group’s dividend payout ratio (DPR) is 52.98%.

TRADEMARK VIOLATION NOTICE: “Baldwin Brothers Inc. MA Maintains Position in CME Group Inc (CME)” was reported by BBNS and is the sole property of of BBNS. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The original version of this news story can be accessed at https://baseballnewssource.com/markets/baldwin-brothers-inc-ma-maintains-position-in-cme-group-inc-cme/635396.html.

CME has been the subject of several research analyst reports. Deutsche Bank AG lifted their price target on shares of CME Group from $136.00 to $137.00 and gave the company a “buy” rating in a research note on Tuesday. Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, March 8th. Jefferies Group LLC reaffirmed a “buy” rating and set a $128.00 price target on shares of CME Group in a research note on Saturday, March 11th. JPMorgan Chase & Co. downgraded shares of CME Group from an “overweight” rating to a “neutral” rating in a research note on Tuesday, January 31st. Finally, Royal Bank of Canada decreased their price target on shares of CME Group from $134.00 to $133.00 and set an “outperform” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $111.54.

In other CME Group news, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction dated Friday, February 3rd. The shares were sold at an average price of $121.00, for a total transaction of $121,000.00. Following the completion of the transaction, the director now owns 6,099 shares in the company, valued at $737,979. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Ronald A. Pankau sold 500 shares of CME Group stock in a transaction dated Friday, February 24th. The stock was sold at an average price of $122.11, for a total transaction of $61,055.00. Following the transaction, the director now owns 3,500 shares of the company’s stock, valued at approximately $427,385. The disclosure for this sale can be found here. Insiders sold 12,931 shares of company stock valued at $1,576,260 in the last quarter. Company insiders own 0.61% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

5 Day Chart for NASDAQ:CME

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with our FREE daily email newsletter.

 

Latest News

Sources Say Luis Robert Will Be Cleared by May 20 to Sign
Sources Say Luis Robert Will Be Cleared by May 20 to Sign
Colorado Rockies Bullpen Helping Them to NL West Lead
Colorado Rockies Bullpen Helping Them to NL West Lead
Hall of Famer Given New Lease on Life
Hall of Famer Given New Lease on Life
New York Mets Have the Power
New York Mets Have the Power
Red Sox Fighting Through Illness and Injury
Red Sox Fighting Through Illness and Injury
Cleveland and Arizona Off to Fast Starts
Cleveland and Arizona Off to Fast Starts


Leave a Reply

 
© 2006-2017 BBNS.